Viewing Study NCT03088293


Ignite Creation Date: 2025-12-25 @ 12:56 AM
Ignite Modification Date: 2026-03-22 @ 6:50 AM
Study NCT ID: NCT03088293
Status: WITHDRAWN
Last Update Posted: 2022-07-20
First Post: 2017-03-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS)
Sponsor: Hospices Civils de Lyon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module